Characterizing Pulmonary Fibrosis Patterns in Post-COVID-19 Patients through Machine Learning Algorithms [PDF]
arXiv, 2023 The COVID-19 pandemic has left a lasting impact on global healthcare systems, with increasing evidence of pulmonary fibrosis emerging as a post-infection complication. This study presents a comprehensive analysis of pulmonary fibrosis patterns in post-COVID-19 patients from South and Central Iraq, employing advanced machine learning algorithms.
arxiv
Growth factors in idiopathic pulmonary fibrosis: relative roles [PDF]
, 2001 Treatment of idiopathic pulmonary fibrosis patients has evolved very slowly; the fundamental approach of corticosteroids alone or in combination with other immunosuppressive agents has had little impact on long-term survival.
Allen, JT, Spiteri, MA
core +3 more sources
A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset. [PDF]
, 2012 OBJECTIVE: A prospective observational study of mycophenolate mofetil (MMF) treatment in patients with diffuse progressive cutaneous systemic sclerosis (SSc) of recent onset.
Jimenez, Sergio A. +3 more
core +3 more sources
Mitochondrial Quality Control in Age-Related Pulmonary Fibrosis. [PDF]
, 2020 Idiopathic pulmonary fibrosis (IPF) is age-related interstitial lung disease of unknown etiology. About 100,000 people in the U.S have IPF, with a 3-year median life expectancy post-diagnosis.
Cuevas-Mora, Karina +2 more
core +1 more source
Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique. [PDF]
, 2015 © 2015, The Author(s).Introduction: There is a lack of agreed and established guidelines for the treatment of acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF).
Bennett, BM +8 more
core +2 more sources
Early respiratory viral infections in infants with cystic fibrosis [PDF]
, 2019 This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Davis, Stephanie D. +9 more
core +2 more sources
BMC Pulmonary Medicine, 2019 Background CFTR modulator therapy with ivacaftor is a treatment option for Cystic Fibrosis (CF) patients with at least one copy of a R117H-7T mutation in the CFTR gene.
Matthias Welsner +3 more
doaj +1 more source
Survival Analysis for Idiopathic Pulmonary Fibrosis using CT Images and Incomplete Clinical Data [PDF]
arXiv, 2022 Idiopathic Pulmonary Fibrosis (IPF) is an inexorably progressive fibrotic lung disease with a variable and unpredictable rate of progression. CT scans of the lungs inform clinical assessment of IPF patients and contain pertinent information related to disease progression.
arxiv
Frontiers in Immunology, 2023 IntroductionAcute myeloid leukemia (AML) is a type of blood cancer that is identified by the unrestricted growth of immature myeloid cells within the bone marrow. Despite therapeutic advances, AML prognosis remains highly variable, and there is a lack of
Zhongzheng Li +8 more
doaj +1 more source
Hunting imaging biomarkers in pulmonary fibrosis: Benchmarks of the AIIB23 challenge [PDF]
, 2023 Airway-related quantitative imaging biomarkers are crucial for examination, diagnosis, and prognosis in pulmonary diseases. However, the manual delineation of airway trees remains prohibitively time-consuming. While significant efforts have been made towards enhancing airway modelling, current public-available datasets concentrate on lung diseases with
arxiv +1 more source